US-Astronaut Terry Virts bereitet bei einem Weltraumspaziergang die ISS auf kommende Raumfahrzeuge vor.
Mittwoch, 20.04.2022 13:54 von | Aufrufe: 112

SHAREHOLDER ALERT: Weiss Law Reminds ATRS, SRRA, HBP, and EMCF Shareholders About Its Ongoing Investigations

US-Astronaut Terry Virts bereitet bei einem Weltraumspaziergang die ISS auf kommende Raumfahrzeuge vor. ©NASA's Marshall Space Flight Center https://creativecommons.org/licenses/by/2.0/

PR Newswire

NEW YORK, April 20, 2022 /PRNewswire/ -- 

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Joshua Rubin, Esq.
Weiss Law
305 Broadway, 7th Floor
New York, NY 10007
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com

Antares Pharma, Inc. (NASDAQ: ATRS)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Antares Pharma, Inc. (NASDAQ: ATRS), in connection with the proposed acquisition of ATRS by Halozyme Therapeutics, Inc. via a tender offer. Under the terms of the merger agreement, ATRS shareholders will receive $5.60 in cash for each share of ATRS common stock owned. If you own ATRS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/atrs

Sierra Oncology, Inc. (NASDAQ: SRRA)


ARIVA.DE Börsen-Geflüster

Kurse

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sierra Oncology, Inc. (NASDAQ: SRRA), in connection with the proposed acquisition of SRRA by GlaxoSmithKline plc. Under the terms of the merger agreement, SRRA shareholders will receive $55.00 in cash for each share of SRRA common stock owned. If you own SRRA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/srra

Huttig Building Products, Inc. (NASDAQ: HBP)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Huttig Building Products, Inc. (NASDAQ: HBP), in connection with the proposed tender offer for HBP by Woodgrain Inc. Under the terms of the tender offer, HBP shareholders will receive $10.70 in cash for each share of HBP common stock owned. If you own HBP shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/hbp

Emclaire Financial Corp (NASDAQ: EMCF)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Emclaire Financial Corp (NASDAQ: EMCF) in connection with its proposed merger with Farmers National Banc Corp. ("Farmers"). Under the terms of the merger agreement, each shareholder of EMCF may elect to receive either $40.00 per share in cash or 2.15 shares of Farmers' common stock, subject to an overall limitation of 70% shares and 30% cash. If you own EMCF shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/emcf

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-atrs-srra-hbp-and-emcf-shareholders-about-its-ongoing-investigations-301529420.html

SOURCE Weiss Law

Werbung

Mehr Nachrichten zur Antares Pharma Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News